XML 47 R7.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
OPERATING ACTIVITIES          
Net (loss) income     $ (4,169) $ 2,186  
Less: Income from discontinued operations, net of income tax   $ (1)   (5,725)  
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:          
Deferred tax expense (benefit)     89 (1,230)  
Loss on debt extinguishment       88  
Depreciation and amortization     1,594 1,395  
Stock-based compensation expense     3,209 2,304  
Bad debt expense     1,332 775  
Loss on disposal of property and equipment     1    
Accretion of debt discount and debt issuance costs       75  
Change in fair value of warrant liabilities $ 11,226 918 12,419 1,561  
Changes in operating assets and liabilities:          
Accounts receivable     (22,344) (15,340)  
Prepaid expenses and current other assets     (452) (322)  
Other assets     (667) 89  
Accounts payable     6,824 7,892  
Accrued expenses and other current liabilities     6,119 4,428  
Net cash provided by (used in) continuing operations     3,955 (1,824)  
Net cash provided by (used in) operating activities     3,955 (1,824)  
INVESTING ACTIVITIES          
Purchase of property and equipment, net     (678) (401)  
Net cash provided by (used in) continuing operations     (678) (401)  
Net cash provided by (used in) discontinued operations     200 2,428  
Net cash provided by (used in) investing activities     (478) 2,027  
FINANCING ACTIVITIES          
Payment of deferred initial public offering costs     (512)    
Repayment of term loan       (5,351)  
Proceeds from revolving line of credit     157,850 35,003  
Repayments made against revolving line of credit     (158,103) (30,715)  
Repurchase of convertible preferred stock       (2,500)  
Repurchase of common stock     (182) (1,205)  
Exercise of stock options     5,007 46  
Net cash provided by (used in) continuing operations     4,060 (4,722)  
Net cash provided by (used in) financing activities     4,060 (4,722)  
Net increase (decrease) in cash and cash equivalents     7,537 (4,519)  
Cash and cash equivalents, beginning of year     127 4,691 $ 4,691
Cash and cash equivalents, end of year $ 7,664 $ 172 7,664 172 $ 127
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION          
Cash paid for interest     176 450  
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES          
Non-cash settlement of liability       414  
Non-cash liability forgiveness related to divestiture       $ 4,869  
Non-cash deferred initial public offering costs in accounts payable and accrued liabilities     $ 2,308